Effects of probiotic on nonalcolic steatohepatitis
Not Applicable
- Conditions
- onalcoholic steatohepatitis.Inflammatory liver disease, unspecified Hepatitis NOS
- Registration Number
- IRCT201204049376N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
patients admitted to Al Zahra hospital over 18 years, who have NASH confirmed by biopsy.
Exclusion criteria: any participant who will take antibiotics for any indication for more than 1 week during the study period or before recruitment to the study; loosing more than 10% of baseline body weight during the study period; autoimmune hepatitis; Wilson's disease; HBV/HCV/HIV/EBV/CMV infection; pregnancy and lactation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alanine transaminase (ALT). Timepoint: Before and after treatment. Method of measurement: Blood test.;Aspartate aminotransferse (AST). Timepoint: before and after treatment. Method of measurement: blood test AST.;Ultrasound Grade of NASH. Timepoint: before and after treatment. Method of measurement: ultrasound.
- Secondary Outcome Measures
Name Time Method Fasting blood suger (FBS). Timepoint: before and after treatment. Method of measurement: blood test.;Chlosterol. Timepoint: befoer and after treatment. Method of measurement: blood test.;Triglyceride. Timepoint: before and after treatment. Method of measurement: blood test.;Body mass index (BMI). Timepoint: before and after treatment. Method of measurement: measure weight and height.